Sillar Clinical

Sillar Clinical

Leuven, Belgium· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sillar Clinical is a Belgian CRO founded in 2018, offering a comprehensive suite of services to guide clients through all phases of clinical development. The company emphasizes a personalized, pragmatic, and creative approach, leveraging a team with over 20 years of industry experience. Its core offerings are structured around three pillars: Clinical Architecture (strategic planning), Clinical Operations (execution), and Clinical Staffing (Functional Service Provision). Sillar's mission is to de-risk and accelerate the path from preclinical research to bringing new medical advances to patients.

Digital Health

Technology Platform

Integrated CRO service methodology built on three pillars: Clinical Architecture (strategic planning), Clinical Operations (execution), and Clinical Staffing (Functional Service Provision). Utilizes a customizable 'AADE concept' to address client-specific needs.

Opportunities

Growing global clinical trials market and increasing outsourcing by biotechs.
The implementation of the EU Clinical Trials Regulation creates demand for regulatory navigation expertise.
Niche demand for agile, personalized CRO services from small to mid-sized biopharma companies.

Risk Factors

Intense competition from large, global CROs.
Revenue dependency on client R&D budgets, which are cyclical.
Reputational risk tied to clinical trial execution success.
Limited public track record as a young company.

Competitive Landscape

Operates in the highly competitive global CRO market, competing against large players (e.g., IQVIA, Parexel, ICON) and numerous mid-sized and regional CROs. Differentiates through a personalized, partnership-focused approach and agility, targeting small to mid-sized biotech and medtech clients who may prefer dedicated service over large-scale providers.